| Financial Year |
March 31 2023 |
| Monetary Funds |
1,916,139,581.50 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
73,478,564.51 |
| Accounts Receivable |
2,012,074,429.01 |
| Advances to Suppliers |
284,876,736.45 |
| Other Receivables |
252,126,552.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
25,386,238.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,617,609,957.55 |
| Total Current Assets |
6,181,692,059.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
17,482,467.64 |
| Long-term Equity Investment |
146,610,550.02 |
| Investment Properties |
91,837,205.40 |
| Fixed Assetes |
4,050,220,807.34 |
| Under-construction Projects |
158,756,132.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
555,124,672.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
196,989,880.53 |
| Deferred Income Tax Assets |
72,938,121.08 |
| Other Non-Current Assets |
122,477,568.65 |
| Sub-Total of Non-Current Assets |
8,241,641,139.91 |
| Total Assets |
14,423,333,199.30 |
| Short-Term Loans |
1,250,916,805.52 |
| Trading Financial liabilities |
-- |
| Notes Payable |
31,911,350.72 |
| Accounts Payable |
2,029,997,561.75 |
| Accounts Received In Advance |
4,898,791.84 |
| Employee Compensation Payable |
776,163,298.80 |
| Taxes Payable |
359,175,712.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
401,273,395.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,181,589,335.65 |
| Other Current Liabilities |
4,952,147.13 |
| Sub-Total of Current Liabilities |
6,123,394,218.22 |
| Long-term Loans |
36,944,683.14 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
57,209,346.88 |
| Deferred Income Tax Liabilities |
272,103,922.39 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,291,213,154.58 |
| Total Liabilities |
7,414,607,372.80 |
| Paid-In Capital(Or Share Stock) |
1,026,957,470.00 |
| Capital Surplus |
921,876,389.65 |
| Surplus Reserve |
462,903,487.32 |
| LESS:Treasury Stock |
160,239,218.93 |
| Undistributed Profits |
4,438,116,120.22 |
| Minority Stockholder's Interest |
-924,102.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,009,649,928.70 |
| Owner's Equity（Stockholder's Equity） |
7,008,725,826.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,423,333,199.30 |
